SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Blumberg Life Sciences Fund Ltd., et al. – ‘4/A’ for 11/18/04 re: Cambridge Heart Inc.

On:  Wednesday, 3/16/05, at 5:23pm ET   ·   For:  11/18/04   ·   As:  10% Owner   ·   Accession #:  898432-5-245   ·   File #:  0-20991

Previous ‘4’:  ‘4/A’ on 3/16/05 for 5/11/04   ·   Next:  ‘4/A’ on 3/16/05 for 11/23/04   ·   Latest:  ‘4’ on 1/23/06 for 1/19/06

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/16/05  Blumberg Life Sciences Fund Ltd.  4/A        10% Owner   1:15K  Cambridge Heart Inc.              K&L Gates LLP/DC/FA
          Blumberg Life Sciences Fund LP
          Afb Fund LLC
          Blumberg Louis
          Blumberg Capital Management LLC
          Blumberg Capital Advisors LLC
          Blumberg Laurence J

Amendment to Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4/A         Amendment to Statement of Changes in Beneficial     HTML     14K 
                Ownership of Securities by an Insider --                         
                laurenceblumberg_ex.xml/2.2


        

This ‘4/A’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
EDGAR System rendering:  Amendment to Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:January 31, 2005
Estimated average burden hours per response...0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
AFB FUND LLC
  2. Issuer Name and Ticker or Trading Symbol
CAMBRIDGE HEART INC [CAMH] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
, 2050 CENTER AVENUE		 3. Date of Earliest Transaction (Month/Day/Year)
11/18/2004
(Street)

FORT LEE,, NJ 07024		 4. If Amendment, Date Original Filed (Month/Day/Year)
11/22/2004		 6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock11/18/2004   S   89,000D $0.55822,093,272ISee footnotes (1) (2)
Common Stock               316,500ISee footnotes (1) (3)
Common Stock               466,128ISee footnotes (1) (4)
Common Stock               63,180ISee footnotes (1) (5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / AddressRelationships
 Director 10% Owner Officer Other
AFB FUND LLC
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG LIFE SCIENCES FUND LP
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG LIFE SCIENCES FUND LTD
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG CAPITAL ADVISORS LLC
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG CAPITAL MANAGEMENT LLC
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG LOUIS
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    
BLUMBERG LAURENCE J
2050 CENTER AVENUE
FORT LEE,, NJ 07024		    X    

Signatures

 /s/ Louis Blumberg, Manager for AFB Fund, LLC***  03/11/2005
**Signature of Reporting PersonDate

 /s/ Laurence J. Blumberg***  03/11/2005
**Signature of Reporting PersonDate

 /s/ Louis Blumberg***  03/11/2004
**Signature of Reporting PersonDate

 /s/ Laurence J. Blumberg, Director for Blumberg Capital Management, L.L.C.***  03/11/2005
**Signature of Reporting PersonDate

 /s/ Laurence J. Blumberg, Director for Blumberg Life Sciences Fund, L.P. *** By Blumberg Capital Advisors, LLC, General Partner  03/11/2005
**Signature of Reporting PersonDate

 /s/ Laurence J. Blumberg, Principal for Blumberg Life Sciences Fund, Ltd.***  03/11/2005
**Signature of Reporting PersonDate

 /s/ Laurence J. Blumberg, Director for Blumberg Capital Advisors, LLC***  03/11/2005
**Signature of Reporting PersonDate

Explanation of Responses:

*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)Each of the Reporting Persons and the joint filers (individually, each a "Reporting Person" and collectively, the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. The Reporting Persons may be deemed to be a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and are reporting beneficial ownership of the securities held by each of the other Reporting Persons as if beneficially owned by each Reporting Person. The information contained in Table I and Table II of this Form 4 replaces, in its entirety, the Form 4 filed 11/22/2004.
(2)These securities are held by AFB Fund, LLC ("AFB"), a New Jersey limited liability company of which Louis Blumberg is the manager and Laurence J. Blumberg is a member. By virtue of Louis Blumberg's position as a manager of AFB, he may be deemed to beneficially own the securities of AFB. By virtue of Laurence J. Blumberg's position as a member of AFB, he may be deemed to beneficially own the securities held by AFB.
(3)These securities are held by Laurence J. Blumberg.
(4)These securities are held by Blumberg Life Sciences Fund, L.P. ("BLSF"). Blumberg Capital Advisors, L.L.C. ("BCA"), the general partner of BLSF, may be deemed to beneficially own these securities by virtue of its position as general partner of BLSF. Blumberg Capital Management, L.L.C. ("BCM") has been delegated investment advisory responsibilities by BCA. BCM may be deemed to beneficially own the securities held by BLSF by virtue of BCM's position as investment manager of BLSF. Laurence J. Blumberg is the managing member of BCM and BCA. By virtue of his position as the managing member of BCM and BCA, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLSF.
(5)These securities are held by Blumberg Life Sciences Fund, Ltd. ("BLS"). BCM is the investment manager of BLS and may be deemed to beneficially own the securities held by BLS by virtue of its position as investment manager of BLS. By virtue of his position as the managing member of BCM, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLS.
 
Remarks:
*** Each of the Reporting Persons disclaims beneficial ownership in the securities reported herein except to the extent of his or its pecuniary interest herein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

↑Top
Filing Submission 0000898432-05-000245   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., Apr. 24, 12:32:35.2am ET